SCHEMBL3479762

SCHEMBL3479762

CN1CCN(c2ccc(F)c(F)c2)c2ccc(C(F)(F)F)cc2C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 4/20 0.49
HTR1A P08908 2/20 0.39
DRD2 P14416 2/20 0.39
HTR2A P28223 2/20 0.39
HTR7 P34969 2/20 0.39
HTR6 P50406 2/20 0.39
NOTUM Q6P988 1/20 0.38
BRD4 O60885 1/20 0.37
DGAT1 O75907 1/20 0.35
SOAT1 P35610 1/20 0.35
KCNH2 Q12809 1/20 0.35
EPHX2 P34913 1/20 0.35
LCK P06239 1/20 0.35
KDR P35968 1/20 0.35
TEK Q02763 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
HRH4 Q9H3N8 2/20 0.34
SRPK1 Q96SB4 1/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3479881 0.87 SCN9A (0.53) SCN9AHTR1ADRD2HTR2ANOTUM
SCHEMBL3228501 0.86 SCN9A (0.53) SCN9ANOTUMDGAT1SOAT1KCNH2
SCHEMBL3479580 0.85 SCN9A (0.48) SCN9AHTR1ADRD2HTR2AHTR7
SCHEMBL3479611 0.84 ALDH1A1 (0.46) SCN9AHTR1ADRD2HTR2AHTR7
SCHEMBL3479826 0.84 SCN9A (0.51) SCN9ADRD2NOTUMKCNH2MEN1
SCHEMBL3222283 0.83 SCN9A (0.54) SCN9AHTR1ADRD2HTR2AHTR6
SCHEMBL3479739 0.83 GAA (0.46) SCN9AHTR1ADRD2HTR6MEN1
SCHEMBL3231298 0.83 SCN9A (0.52) SCN9AHTR1ADRD2HTR2AHTR7
SCHEMBL3227422 0.83 SCN9A (0.52) SCN9ADRD2HTR2ANOTUMKCNH2
SCHEMBL3479697 0.82 SCN9A (0.37) SCN9AHTR6BRD4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096546-B2 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin ALBANY MOLECULAR RESEARCH, INC. (US) 2015-08-04 US disclosed
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ADRA1B, ADRB1, ADRA1D SCN9A 795/4885HTR1A 16/4885DRD2 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.